← Every company
BridgeBio Pharma Inc SEC Filings
What BridgeBio Pharma Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.
BBIO overview →Filings on file
111
since May 24, 2019
Warning signs
0
none filed
Last results
Aug 10, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834
Newest first
Each label is a form type or an 8-K item as filed; each row links to the filing.
| Filed | What it reports | Document |
|---|---|---|
| Aug 10, 2026 | Results announced 8-K | Read ↗ |
| May 7, 2026 | Results announced 8-K | Read ↗ |
| Feb 24, 2026 | Results announced 8-K | Read ↗ |
| Jan 12, 2026 | Results announced 8-K | Read ↗ |
| Oct 29, 2025 | Results announced 8-K | Read ↗ |
| Aug 5, 2025 | Results announced 8-K | Read ↗ |
| Apr 29, 2025 | Results announced 8-K | Read ↗ |
| Feb 20, 2025 | Results announced 8-K | Read ↗ |
| Jan 13, 2025 | Results announced 8-K | Read ↗ |
| Nov 12, 2024 | Results announced 8-K | Read ↗ |
| Aug 1, 2024 | Results announced 8-K | Read ↗ |
| May 2, 2024 | Results announced 8-K | Read ↗ |
| Feb 22, 2024 | Results announced 8-K | Read ↗ |
| Nov 2, 2023 | Results announced 8-K | Read ↗ |
| Aug 3, 2023 | Results announced 8-K | Read ↗ |
| May 4, 2023 | Results announced 8-K | Read ↗ |
| Feb 23, 2023 | Executive or director changeResults announced 8-K | Read ↗ |
| Nov 3, 2022 | Results announced 8-K | Read ↗ |
| Aug 4, 2022 | Results announced 8-K | Read ↗ |
| May 10, 2022 | Results announced 8-K | Read ↗ |
| Feb 24, 2022 | Results announced 8-K | Read ↗ |
| Nov 4, 2021 | Results announced 8-K | Read ↗ |
| Aug 13, 2021 | Results announced 8-K | Read ↗ |
| May 14, 2021 | Results announced 8-K | Read ↗ |
| Feb 26, 2021 | Results announced 8-K | Read ↗ |
| Nov 5, 2020 | Results announced 8-K | Read ↗ |
| Aug 11, 2020 | Results announced 8-K | Read ↗ |
| May 13, 2020 | Results announced 8-K | Read ↗ |
| Mar 2, 2020 | Results announced 8-K | Read ↗ |
| Dec 26, 2019 | Results announced 8-K | Read ↗ |
Source: BridgeBio Pharma Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.
More on BBIO
Company overviewEverything on BBIO in one place, with the price.Insider tradingWhat BBIO's own officers and directors buy and sell.Executive payWhat BBIO awarded its chief executive, and what it became.Who owns itEvery manager reporting a position in BBIO.Funds holding itWhich funds and ETFs hold BBIO, and how big a bet.LobbyingWhat BBIO spends lobbying Congress, and on what.Who lobbies for itThe lobbyists on BBIO's account, and who they worked for.